BofA Securities Upgrades Ionis Pharmaceuticals (IONS) to Neutral, 'Higher revenue potential'

October 23, 2023 6:04 AM EDT Send to a Friend
(Updated - October 23, 2023 6:12 AM EDT)

BofA Securities analyst Jason Gerberry upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login